Skip to content

A prospective cohort study of the assessment of fractional flow reserve for the endovascular treatment of atherosclerotic obliterans

A prospective cohort study of the assessment of fractional flow reserve for the endovascular treatment of atherosclerotic obliterans

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060025
Enrollment
Unknown
Registered
2022-05-15
Start date
2022-05-15
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerotic obliterans (ASO)

Interventions

Sponsors

Zhongshan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. No gender limit, aged >=18 years; 2. The length of femoral popliteal lesions is less than or equal to 20cm; 3. Lesion stenosis >=50% or completely occlusive disease; 4. Rutherford grade 2-5.

Exclusion criteria

Exclusion criteria: 1. No run-off vessels; 2. The common femoral artery bifurcation lesion; 3. Acute thrombotic lesions; 4. Patients with aneurysms of the iliac artery and common femoral artery; 5. Severe renal insufficiency (creatinine>250umol/L, non-dialysis state), contrast agent allergy, coagulation dysfunction, etc. cannot tolerate surgery; 6. Life expectancy <1 year.

Design outcomes

Primary

MeasureTime frame
primary patency;

Secondary

MeasureTime frame
clinically driven target lesion reintervention;technical success;ankle brachial index;Rutherford grade;numerical rating scale;SF-26V2 health survey;ulcer healing;

Countries

China

Contacts

Public ContactDong Zhihui

Zhongshan Hospital, Fudan University

dzh926@126.com+86 13564249168

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026